Chemed Corp. Aktie
Neueste Einschätzungen
Deine Einschätzung
Chemed Corp. Aktie
Was spricht für und gegen Chemed Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Chemed Corp. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Chemed Corp. | 0,97 % | -7,96 % | -11,86 % | 4,84 % | 0,00 % | 34,02 % | 81,31 % |
Amn Healthcare Svs | 2,78 % | 6,73 % | 3,74 % | -26,00 % | -17,16 % | -15,27 % | 21,80 % |
Select Medical Holdings | 0,78 % | 1,56 % | -3,70 % | -2,26 % | 20,37 % | -17,20 % | 106,41 % |
Neogenomicsinc. | -1,53 % | 8,66 % | 0,00 % | 3,76 % | -11,54 % | -66,11 % | - |
Kommentare
News
Chemed Reports First-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the